Research

Hormonal

Diverting bile flow to the distal small intestine (ileum) produces weight loss and metabolic improvements comparable to Roux-en-Y gastric bypass (RYGB) surgery.

This research suggests that the metabolic benefits of bariatric surgery (like RYGB) are largely driven by how bile acids are delivered to the intestine, specifically the ileum. While this specific surgical procedure (GB-IL) is not a standard clinical option yet, it highlights that manipulating bile acid signaling could be a key target for future non-surgical or less invasive treatments for obesity and type 2 diabetes. For now, standard bariatric surgery remains the most effective surgical option, but understanding this mechanism may lead to new drugs or simpler procedures.

GoodSupportsHIGH confidence
We show that when compared in this manner, bile diversion to the ileum results in metabolic remission that is equal or slightly superior to RYGB.
Charles R. Flynn et al. · Nature Communications · 2015

Why this rating

High-quality animal model (mouse) with rigorous controls, though translation to human surgery requires caution.

Source

Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery

Charles R. Flynn et al. · Nature Communications · 2015

DOI 10.1038/ncomms8715

mechanism_onlyCited 173×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →